Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left heart and biventricular bypass.

E Jorge1, W E Pae, W S Pierce

  • 1Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.

Critical Care Clinics
|April 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nox1-derived oxidative stress as a common pathogenic link between obesity and hyperoxaluria-related kidney injury.

Urolithiasis·2019
Same author

Robotic versus laparoscopic distal pancreatectomy: A comparative study of clinical outcomes and costs analysis.

International journal of surgery (London, England)·2017
Same author

Laparoscopic left ureteral substitution using the cecal appendix after en-bloc rectosigmoidectomy: a case report and video demonstration.

Techniques in coloproctology·2017
Same author

Robotic versus laparoscopic surgery for rectal cancer: a comparative study of clinical outcomes and costs.

International journal of colorectal disease·2017
Same author

Metabolic syndrome contributes to renal injury mediated by hyperoxaluria in a murine model of nephrolithiasis.

Urolithiasis·2017
Same author

Utilization of enzyme markers to determine the location of plasma membrane from Pisum epicotyls on sucrose gradients.

Planta·2013
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Ventricular assist devices (VADs) offer a promising option for patients with severe heart conditions, including cardiogenic shock and those awaiting heart transplants. While outcomes are modest, VADs provide crucial support for patients with a poor prognosis.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering

Background:

  • Ventricular assist devices (VADs) are advanced medical technologies designed to support cardiac function.
  • Current VADs include roller-pump-driven and pneumatically powered systems.

Purpose of the Study:

  • To review the clinical application and efficacy of various circulatory assist devices.
  • To highlight the role of VADs in managing cardiogenic shock and as a bridge to cardiac transplantation.

Main Methods:

  • Review of existing clinical data and applications of ventricular bypass devices.
  • Analysis of patient outcomes in cardiogenic shock and those awaiting transplantation.

Main Results:

  • VADs are clinically utilized for patients in cardiogenic shock post-cardiac surgery or myocardial infarction, when conventional therapies fail.

Related Experiment Videos

  • Modest but encouraging success rates are observed in high-risk patient populations.
  • VADs show potential for supporting patients awaiting cardiac transplantation.
  • Conclusions:

    • Ventricular assist devices represent a vital therapeutic option for end-stage heart failure.
    • The role of VADs is expanding, particularly in bridging patients to cardiac transplantation.